Hong Kong stock abnormal | Rongchang Biology (09995.HK) rose more than 7% in the closing session. Taitsip reached an authorization agreement. Institutions said that it is expected to be approved in the United States, but clinical data is still needed.
According to the Securities Times app, Rongchang Biology (09995.HK) surged more than 7% in the final trading session, with a 6.15% increase at the time of publication, closing at HK$58.65 and trading volume of HK$823 million.
Latest
